Literature DB >> 24628444

Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes.

C N Castro1, A E Barcala Tabarrozzi, J Winnewisser, M L Gimeno, M Antunica Noguerol, A C Liberman, D A Paz, R A Dewey, M J Perone.   

Abstract

Type 1 diabetes (T1DM) is a T cell-mediated autoimmune disease that selectively destroys pancreatic β cells. The only possible cure for T1DM is to control autoimmunity against β cell-specific antigens. We explored whether the natural compound curcumin, with anti-oxidant and anti-inflammatory activities, might down-regulate the T cell response that destroys pancreatic β cells to improve disease outcome in autoimmune diabetes. We employed two accelerated autoimmune diabetes models: (i) cyclophosphamide (CYP) administration to non-obese diabetic (NOD) mice and (ii) adoptive transfer of diabetogenic splenocytes into NODscid mice. Curcumin treatment led to significant delay of disease onset, and in some instances prevented autoimmune diabetes by inhibiting pancreatic leucocyte infiltration and preserving insulin-expressing cells. To investigate the mechanisms of protection we studied the effect of curcumin on key immune cell populations involved in the pathogenesis of the disease. Curcumin modulates the T lymphocyte response impairing proliferation and interferon (IFN)-γ production through modulation of T-box expressed in T cells (T-bet), a key transcription factor for proinflammatory T helper type 1 (Th1) lymphocyte differentiation, both at the transcriptional and translational levels. Also, curcumin reduces nuclear factor (NF)-κB activation in T cell receptor (TCR)-stimulated NOD lymphocytes. In addition, curcumin impairs the T cell stimulatory function of dendritic cells with reduced secretion of proinflammatory cytokines and nitric oxide (NO) and low surface expression of co-stimulatory molecules, leading to an overall diminished antigen-presenting cell activity. These in-vitro effects correlated with ex-vivo analysis of cells obtained from curcumin-treated mice during the course of autoimmune diabetes. These findings reveal an effective therapeutic effect of curcumin in autoimmune diabetes by its actions on key immune cells responsible for β cell death.
© 2014 British Society for Immunology.

Entities:  

Keywords:  NOD mouse; T lymphocytes; T-bet; dendritic cells; inflammation

Mesh:

Substances:

Year:  2014        PMID: 24628444      PMCID: PMC4089164          DOI: 10.1111/cei.12322

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  59 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

2.  Curcumin: getting back to the roots.

Authors:  Shishir Shishodia; Gautam Sethi; Bharat B Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2005-11       Impact factor: 5.691

3.  Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.

Authors:  P Augstein; A G Elefanty; J Allison; L C Harrison
Journal:  Diabetologia       Date:  1998-11       Impact factor: 10.122

4.  Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice.

Authors:  J Morin; B Faideau; M-C Gagnerault; F Lepault; C Boitard; S Boudaly
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

5.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

Review 6.  Molecular mechanisms of curcumin action: signal transduction.

Authors:  Adeeb Shehzad; Young Sup Lee
Journal:  Biofactors       Date:  2013-01-10       Impact factor: 6.113

Review 7.  An update on preventive and regenerative therapies in diabetes mellitus.

Authors:  M Reimann; E Bonifacio; M Solimena; P E H Schwarz; B Ludwig; M Hanefeld; S R Bornstein
Journal:  Pharmacol Ther       Date:  2008-12-25       Impact factor: 12.310

8.  Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.

Authors:  Jun Sun; Yi Zhao; Jinhong Hu
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

9.  Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells.

Authors:  Ana C Liberman; Maria Antunica-Noguerol; Viviane Ferraz-de-Paula; Joao Palermo-Neto; Carla N Castro; Jimena Druker; Florian Holsboer; Marcelo J Perone; Sarah Gerlo; Karolien De Bosscher; Guy Haegeman; Eduardo Arzt
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

10.  Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells.

Authors:  Angela J Fahey; R Adrian Robins; Cris S Constantinescu
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

View more
  20 in total

1.  Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus.

Authors:  Raghu Ganugula; Meenakshi Arora; Patcharawalai Jaisamut; Ruedeekorn Wiwattanapatapee; Heather G Jørgensen; Vinod P Venkatpurwar; Beiyan Zhou; Aline Rodrigues Hoffmann; Rita Basu; Shaodong Guo; Naga Venkata Ravi Kumar Majeti
Journal:  Br J Pharmacol       Date:  2017-05-30       Impact factor: 8.739

2.  Immunomodulatory Effects of Curcumin in Rheumatoid Arthritis: Evidence from Molecular Mechanisms to Clinical Outcomes.

Authors:  Saeed Mohammadian Haftcheshmeh; Arezou Khosrojerdi; Ali Aliabadi; Shadi Lotfi; Asadollah Mohammadi; Amir Abbas Momtazi-Borojeni
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

3.  Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

Authors:  Charlotta D Mock; Brian C Jordan; Chelliah Selvam
Journal:  RSC Adv       Date:  2015-09-02       Impact factor: 3.361

Review 4.  Natural Insulin Sensitizers for the Management of Diabetes Mellitus: A Review of Possible Molecular Mechanisms.

Authors:  Habib Yaribeygi; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

Review 6.  Curcumin: a modulator of inflammatory signaling pathways in the immune system.

Authors:  Kolsoum Rezaie Kahkhaie; Ali Mirhosseini; Ali Aliabadi; Asadollah Mohammadi; Mohammad Javad Mousavi; Saeed Mohammadian Haftcheshmeh; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Inflammopharmacology       Date:  2019-05-28       Impact factor: 5.093

Review 7.  Diabetic cardiomyopathy and its prevention by nrf2: current status.

Authors:  Jing Chen; Zhiguo Zhang; Lu Cai
Journal:  Diabetes Metab J       Date:  2014-10       Impact factor: 5.376

8.  Multivariate analysis and molecular interaction of curcumin with PPARγ in high fructose diet induced insulin resistance in rats.

Authors:  Vasanthi Jayakumar; Shiek S S J Ahmed; Kesavarao Kumar Ebenezar
Journal:  Springerplus       Date:  2016-10-06

9.  Pluripotent Nontumorigenic Adipose Tissue-Derived Muse Cells have Immunomodulatory Capacity Mediated by Transforming Growth Factor-β1.

Authors:  María L Gimeno; Florencia Fuertes; Andres E Barcala Tabarrozzi; Alejandra I Attorressi; Rodolfo Cucchiani; Luis Corrales; Talita C Oliveira; Mari C Sogayar; Leticia Labriola; Ricardo A Dewey; Marcelo J Perone
Journal:  Stem Cells Transl Med       Date:  2016-08-02       Impact factor: 6.940

Review 10.  Chronic diseases, inflammation, and spices: how are they linked?

Authors:  Ajaikumar B Kunnumakkara; Bethsebie L Sailo; Kishore Banik; Choudhary Harsha; Sahdeo Prasad; Subash Chandra Gupta; Alok Chandra Bharti; Bharat B Aggarwal
Journal:  J Transl Med       Date:  2018-01-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.